Giripladib

CAS No. 865200-20-0

Giripladib( —— )

Catalog No. M34608 CAS No. 865200-20-0

Giripladib (PLA695)(PLX-695) is a cPLA2-specific inhibitor that inhibits the radiation-induced increase of phosphorylated ERK and phosphorylated Akt in endothelial cells.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 623 In Stock
5MG 426 In Stock
10MG 625 In Stock
25MG 938 In Stock
50MG 1283 In Stock
100MG 1758 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Giripladib
  • Note
    Research use only, not for human use.
  • Brief Description
    Giripladib (PLA695)(PLX-695) is a cPLA2-specific inhibitor that inhibits the radiation-induced increase of phosphorylated ERK and phosphorylated Akt in endothelial cells.
  • Description
    Giripladib (PLA-695) is a indole-based inhibitor of cytosolic phospholipase A2 (cPLA2). Giripladib can be used for osteoarthritis and breast cancer research.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Phospholipase
  • Recptor
    Phospholipase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    865200-20-0
  • Formula Weight
    745.25
  • Molecular Formula
    C41H36ClF3N2O4S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(N1C(CCNS(CC2=C(C(F)(F)F)C=CC=C2)(=O)=O)=C(CCCC3=CC=C(C(O)=O)C=C3)C=4C1=CC=C(Cl)C4)(C5=CC=CC=C5)C6=CC=CC=C6
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Kokotos G, et al. Inhibition of group IVA cytosolic phospholipase A2 by thiazolyl ketones in vitro, ex vivo, and in vivo. J Med Chem. 2014 Sep 25;57(18):7523-35.?
molnova catalog
related products
  • VU0155069

    VU0155069 strongly inhibits the invasive migration of several cancer cell lines in transwell assays. VU0155069 is a selective phospholipase D1 inhibitor (IC50: 46 nM in vitro).

  • Vinaxanthone

    Vinaxanthone (SM-345431) is a small molecule compound derived from Penicillium chrysogenum that acts as a selective and potent inhibitor of semaphorin3A, phospholipase C (PLC), and FabI, exhibiting antimicrobial activity by blocking intracellular fatty acid synthesis and inhibiting the growth of Staphylococcus aureus.

  • Lp-PLA2-IN-1

    Lp-PLA2 -IN-1 suppresses Lp-PLA2 activity processes for their preparation.